Martin Langer

Also affiliated with Associazione Italiana Vulvodinia Onlus, Marymount University

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Non-inferiority versus superiority trial design for new antibiotics in an era of high antimicrobial resistance: the case for post-marketing, adaptive randomised controlled trials”.

Non-inferiority versus superiority trial design for new antibiotics in an era of high antimicrobial resistance: the case for post-marketing, adaptive randomised controlled trials

The Lancet Infectious Diseases(2019)10.1016/s1473-3099(19)30284-1

N/A

0.464DataRank · unranked

21 citations

John P. A. Ioannidis, Francesco Vairo, Michel Pletschette, Gina Portella, Virginia Di Bari +13 more

Comorbidity status of deceased COVID-19 in-patients in Italy

Aging Clinical and Experimental Research(2021)10.1007/s40520-021-01914-y

N/A

0DataRank · unranked

16 citations

Clare Tazzeo, Luigi Palmieri, Alessandra Marengoni, Alberto Zucchelli, Cinzia Lo Noce +65 more